Detailed Information on Publication Record
2020
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report
KOLČAVA, Jan, Jiří LITZMAN, Josef BEDNAŘÍK, Jakub STULÍK, Pavel ŠTOURAČ et. al.Basic information
Original name
Neurological manifestation of immune system dysregulation resulting from CTLA-4 receptor mutation: a case report
Name in Czech
Neurologická manifestace dysregulace imunitního systému při mutaci CTLA-4: kazuistika
Authors
KOLČAVA, Jan (203 Czech Republic, belonging to the institution), Jiří LITZMAN (203 Czech Republic, belonging to the institution), Josef BEDNAŘÍK (203 Czech Republic, belonging to the institution), Jakub STULÍK (203 Czech Republic) and Pavel ŠTOURAČ (203 Czech Republic, guarantor, belonging to the institution)
Edition
MULTIPLE SCLEROSIS AND RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2020, 2211-0348
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30103 Neurosciences
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.339
RIV identification code
RIV/00216224:14110/20:00116076
Organization unit
Faculty of Medicine
UT WoS
000582230900002
Keywords in English
CTLA-4 antigen; T-lymphocytes; Autoimmunity; Genetic diseases; Demyelinating diseases
Tags
International impact, Reviewed
Změněno: 13/5/2021 07:44, Mgr. Tereza Miškechová
Abstract
V originále
This contribution reports the case of a young female patient with a cytotoxic T-lymphocyte antigen 4 (CTLA-4) heterozygous missense mutation giving rise to a broad range of autoimmune diseases, including central nervous system inflammation presenting as disseminated intramedullary and infiltrating brain lesions on MRI. Multiple sclerosis was one of the diagnoses considered. CTLA-4 is a negative immune regulator essential for the function of regulatory T-cells, themselves responsible for maintaining self-tolerance and immune homeostasis. Heterozygous germline mutations in CTLA-4 may lead to an autosomal dominant immune dysregulation syndrome with highly variable phenotype, including various immunodeficiency and autoimmune diseases, along with neurological manifestations.
Links
MUNI/A/1325/2019, interní kód MU |
|